Expression of retinoic acid receptor β in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid

Clinical Cancer Research

Volumn 2, Issue 6, 1996, Pages 1077-1082

  Hoffman, Anthony D ^a   Engelstein, Dov ^a   Bogenrieder, Thomas ^a   Papandreou, Christos N ^a   Steckelman, Eric ^a   Dave, Ami ^a   Motzer, Robert J ^a   Dmitrovsky, Ethan ^a   Albino, Anthony P ^a   Nanus, David M ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; MESSENGER RNA; RETINOIC ACID RECEPTOR;

ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BLOTTING, SOUTHERN; CARCINOMA, RENAL CELL; CELL DIVISION; HUMANS; ISOTRETINOIN; KIDNEY NEOPLASMS; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030007752     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Gudas, L. J. Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth & Differ., 3: 655-662, 1992.
2. McBurney, M. W., Costa, S., and Pratt, M. A. C. Retinoids and cancer: a basis for differentiation therapy. Cancer Invest., 11: 590-598, 1993.
3. Smith, M. A., Parkinson, D. P., Cheson, B. D., and Friedman, M. A. Retinoids in cancer therapy. J. Clin. Oncol., 10: 839-864, 1992.
4. Miller, W. H., Jr., Moy, D., Li, A., Grippo, J. F., and Dmitrovsky, E. Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line. Oncogene, 5: 511-517, 1990.
5. Zou, C. P., Clifford, J. L., Xu, X. C., Sacks, P. G., Chambon, P., Hong, W. K., and Lotan, R. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res., 54: 5479-5487, 1994.
6. Warrell, R. P., Jr., Frankel, S. R., Miller, W. H., Jr., Scheinber, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M. A., and Dmitrovsky, E. Differentiation therapy of acute promyelocytic leukemia with retinoin (all-trans-retinoic acid). N. Engl. J. Med., 324: 1385-1393, 1991.
7. Garewal, H. S. Chemoprevention of Barrett's esophagus and oral leukoplakia. Adv. Exp. Med. Biol, 320: 129-136, 1992.
8. Scully, C , and Boyle, P. Vitamin A-related compounds in the chemoprevention of potentially malignant oral lesions and carcinoma (Review). Eur. J. Cancer. 28B: 87-89, 1992.
9. Evans, R. The steroid and thyroid hormone receptor superfamily. Science (Washington DC), 240: 889-895, 1988.
10. Pemrick, S. M , Lucas, D. A., and Grippo, J. F. The retinoid receptors. Leukemia (Baltimore), 8 (Suppl. 3): 1-10, 1994.
11. Chambon, P. The retinoid signaling pathway: molecular and genetic analyses. Semin. Cell Biol , 5: 115-125, 1994.
12. Collins, S. J., Robertson, K. A., and Muellar, L. Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-α). Mol. Cell. Biol., 10: 2154-2163, 1990.
13. Geradts, J., Chen, J. Y., Russell, E. K., Yankaskas, J. R., Nieves, L , and Minna, J. D. Human lung cancer cell lines exhibit resistance to retinoic acid treatment Cell Growth & Differ., 4: 799-809, 1993.
14. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Peacocke, M., and Sager, R. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth & Differ., 5: 133-141, 1994.
15. Moasser, M. M., DeBlasio, A., and Dmitrovsky, E. Response and resistance to retinoic acid are mediated through the retinoic acid receptor, in human teratocarcinomas. Oncogene, 9: 833-840, 1994.
16. Moasser, M. M., Reuter, V. E., and Dmitrovsky, E. Overexpression of the retinoic acid receptor γ directly induces terminal differentiation of human embryonal carcinoma cells. Oncogene. 10: 1537-1543, 1995.
17. Kakizuka, A., Miller, W. H., Jr., Umesono, K., Warrell, R. P., Jr., Frankel S. R., Murty, V. V., Dmitrovsky, E., and Evans, R. M. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR-α with a novel putative transcription Cell, 66: 663-674, 1991.
18. Sheikh, M. S., Shao, Z. M., Li, X. S., Dawson, M , Jetten, A. M., Wu, S., Conley, B A., Garcia, M., Rochefort, H., and Fontana, J. A. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor α acquire sensitivity to growth inhibition by retinoids. J. Biol. Chem., 269: 21440-21447, 1994.
19. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics, 1995. CA Cancer J. Clin., 45: 8-30, 1995.
20. Motzer, R. J., Schwartz, P., Murray Law, T., Hoffman, A. D., Albino, A. P., Vlamis, V., and Nanus, D. M. Antitumor effects of IFN-α-2a and 13 cis-retinoic acid in renal cell carcinoma: results of a Phase II trial and in vitro studies. J. Clin. Oncol., 13: 1950-1957, 1995.
21. Minasian, L. M., Motzer, R. J., Gluck, L., Mazumdar, M., Vlamis, V., and Krown, S. E. IFN-α-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up. J. Clin. Oncol., 11: 1368-1375, 1993.
22. Toma, S., Monteghirfo, S., Tasso, P., Nicolo, G., Spadini, N., Palumbo, R., and Molina, F. Antiproliferative and synergistic effect of IFN-α-2a, retinoids and their association in established human cancer cell lines. Cancer Lett., 82: 209-216, 1994.
23. Dmitrovsky, E., and Bosl, G. J. Active cancer therapy combining 13-cis-retinoic acid with IFN-α. J. Natl. Cancer Inst., 84: 218-219, 1992.
24. Nanus, D. M., Pfeffer, L. M., Bander, N. H., Bahri, S., and Albino, A. P. Antiproliferative and antitumor effects of IFN-α in renal cell carcinomas: correlation with the expression of a kidney associated differentiation glycoprotein. Cancer Res., 50: 4190-4194, 1990.
25. Beniers, A. J., Peelen, W. P., Hendriks, B. T., Schalken, J. A., and Debruyne, F. M. Effect of IFN-α and -γ and tumor necrosis factor on colony formation of two human renal tumor xenografts in vitro. Semin. Surg. Oncol., 4: 195-198, 1988.
26. Biers, J. M. C., Peelen, W. P., Debruyne, F. M. J., and Schalken, J. A. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for IFN-α, IFN-γ, and TNF. Int. J. Cancer, 48: 709-716, 1991.
27. Ebert, T., Bander, N. H., Finstad, C. L., Ramsawak, R. D., and Old, L. J. Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res., 50: 5531-5536, 1990.
28. Andrews, P. W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol., 103: 285-293, 1984.
29. Brand, N., Petkovich, M., Krust, A , Chambon, P., The, H. D., Marchio, A , Tiollais, P., and Dejean, A. Identification of a second human retinoic acid receptor. Nature (Lond.), 332: 851-853, 1988.
30. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A., and Evans, R. M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature (Lond.), 345: 224-229, 1990.
31. Krust, A., Kastner, P , Petkovich, M., Zelent, A., and Chambon, P. A third human retinoic acid receptor, hRAR-γ. Proc. Natl. Acad. Sci. USA, 86: 5310-5314, 1989.
32. Thomas, P. S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl. Acad. Sci. USA, 77: 5201-5205, 1980.
33. Nanus, D. M., Engelstein, D., Gastl, G. A., Gluck, L., Vidal, M. J., Morrison, M , Finstad, C. L., Bander, N. H., and Albino, A. P. Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. Proc. Natl. Acad. Sci. USA, 90: 7069-7073, 1993.
34. Tso, J. Y., Sun, X-H , Kao, T., Reece, K S., and Wu, R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene Nucleic Acids Res., 13: 2485-2502, 1985.
35. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
36. Albino, A. P., Davis, B. M., and Nanus, D. M. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res., 51: 4815-4820, 1991.
37. Ng, S. Y., Gunning, P., Eddy, R., Ponte, P., Leavitt, J., Shows, T., and Kedes, L. Evolution of the functional human β-actin gene and its multipseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol. Cell. Biol., 5: 2720-2732, 1985.
38. Houle, B., Pelletier, M., Wu, J., Goodyer, C., and Bradley, W. E. C. Fetal isoform of human retinoic acid receptor β expressed in small cell lung cancer lines. Cancer Res., 54: 365-369, 1994.
39. van der Leede, B. M., Opdenoordt, T. van den Brink, C. E., Ebert, T., and van der Saag, P. T. Implication of retinoic acid receptor β in renal cell carcinoma. Int. J. Oncol., 6: 391-400, 1995.
40. Crettaz, M., Baron, A., and Siegenthaler, G. Ligand specificities of recombinant retinoic acid receptors RAR-α and RAR-β. Biochem. J., 272: 391-397, 1990.
41. Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., and Thaller, C. 9-cis-Retinoic acid is a high affinity ligand for the retinoid Cell, 68: 397-406, 1992.
42. van der Leede, B. M., van den Brink, C. E., and van der Saag, P. T. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines. Mol. Carcinog., 8: 112-122, 1993.
43. Houle, B., Rochette-Egly, C., and Bradley, W. E. C. Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc. Natl. Acad. Sci. USA, 90: 985-989, 1993.
44. Brauch, H , Johnson, B., Hovis, J., Yano, T., Gazdar, A., Pettengill, O. S., Graziano, S., Sorenson, G. D., Poiesz, B. J., Minna, J., Linehan, M., and Zbar, B. Molecular analysis of the short arm of chromosome 3 in small cell and non-small cell carcinoma of the lung. N. Engl. J Med., 317: 1109-1113, 1987.
45. Zbar, B., Brauch, H., Talmadge, C., and Linehan, M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature (Lond.), 327: 721-724, 1987.
46. Anglard, P., Tory, K., Brauch, H., Weiss, G. H., Latif, F., Merino, M. J., Lerman, M. I., Zbar, B., and Linehan, W. M. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res., 51: 1071-1077, 1991.
47. Gebert, J. F., Moghal, N., Frangioni, J. V., Sugarbaker, D. J., and Neel, B. G. High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene, 6: 1859-1868, 1991.
48. Moghal, N., and Neel, B. G. Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol. Cell. Biol., 15: 3945-3959, 1995.
49. Lotan, R., Dawson, M. I., Zou, C. C., Jong, L., Lotan, D., and Zou, C. P. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and IFN-α in inhibition of cervical carcinoma cell proliferation. Cancer Res., 55: 232-236, 1995.
50. Hong, W. K., Lippman, S. M., Hittelman, W. N., and Lotan, R. Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin. Cancer Res., 1: 677-686, 1995.
51. Loan, R., Xu, X. C., Lippman, S. M., Ro, J. Y., Lee, J. S., Lee, J. J., and Hong, W. K. Suppression of retinoic acid receptor β in premalignant oral lesions and its up-regulation by isoretinoin. N. Engl. J. Med., 332: 1405-1410, 1995.
52. Rochette Egly, C. Gaub, M. P., Lutz, Y., Ali, S., and Scheuer, I. Retinoic acid receptor β: immunodetection and phosphorylation. Mol. Endocrinol., 6: 2197-2209, 1992.